Darya Chudova - 09 Sep 2023 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Chief Technology Officer
Signature
/s/ John G. Saia, as attorney-in-fact for Darya Chudova
Issuer symbol
GH
Transactions as of
09 Sep 2023
Net transactions value
-$33,922
Form type
4
Filing time
11 Sep 2023, 17:52:55 UTC
Previous filing
08 Aug 2023
Next filing
29 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH COMMON STOCK Options Exercise $0 +2,908 +21% $0.000000 16,686 09 Sep 2023 Direct
transaction GH COMMON STOCK Tax liability $33,922 -1,006 -6% $33.72 15,680 09 Sep 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH RESTRICTED STOCK UNITS Options Exercise $0 -2,908 -50% $0.000000 2,909 09 Sep 2023 COMMON STOCK 2,908 $0.000000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2 The restricted stock unit award was granted on September 11, 2020, of which 5,817 shares were outstanding on May 3, 2023, when elected as an executive officer. These shares vest 25% on September 9, 2023, and September 9, 2024.
F3 Not applicable for Restricted Stock Units.